Notice2021-25689
Notice Pursuant to the National Cooperative Research and Production Act of 1993-Medical CBRN Defense Consortium
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
November 24, 2021
Issuing agencies
Justice DepartmentAntitrust Division
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 224 (Wednesday, November 24, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 224 (Wednesday, November 24, 2021)]
[Notices]
[Page 67082]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-25689]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National Cooperative Research and
Production Act of 1993--Medical CBRN Defense Consortium
Notice is hereby given that, on September 30, 2021, pursuant to
Section 6(a) of the National Cooperative Research and Production Act of
1993, 15 U.S.C. 4301 et seq. (``the Act''), Medical CBRN Defense
Consortium (``MCDC'') has filed written notifications simultaneously
with the Attorney General and the Federal Trade Commission disclosing
changes in its membership. The notifications were filed for the purpose
of extending the Act's provisions limiting the recovery of antitrust
plaintiffs to actual damages under specified circumstances.
Specifically, Arete Associates, Northridge, CA; Cornerstone Research
Group, Miamisburg, OH; Design West Technologies, Tustin, CA; eSpin
Technologies, Inc., Chattanooga, TN; First Line Technology LLC,
Chantilly, VA; Hermtac LLC, Dallas, TX; Integrated Solutions for
Systems, Huntsville, AL; ITL LLC dba ITL Solutions, Hampton, VA;
Kuprion, Inc., San Jose, CA; Lynntech, Inc., College Station, TX;
Materials Modification, Inc., Fairfax, VA and Microsoft Corporation,
Redmond, WA have been added as parties to this venture.
Also, Adjuvance Technologies, Inc., Lincolc, NE; and Applied
Nanotech, Inc., Austin, TX; Aradigm Corporation; Neward, CA; BioSAFE
Engineering LLC, Indianapolis, IN; Equivital, Inc., New York, NY; EWI,
Columbus, OH; Fast Track Drugs and Biologics LLC, Poolesville, MD;
SINTX Technologies, Inc., Salt Lake City, UT; Somnio Global LLC, Novi,
MI and Visionary Products, Inc., Draper, UT have withdrawn as parties
to this venture.
No other changes have been made in either the membership or planned
activity of the group research project. Membership in this group
research project remains open, and MCDC intends to file additional
written notifications disclosing all changes in membership.
On November 13, 2015, MCDC filed its original notification pursuant
to Section 6(a) of the Act. The Department of Justice published a
notice in the Federal Register pursuant to Section 6(b) of the Act on
January 6, 2016 (81 FR 513).
The last notification was filed with the Department on July 1,
2021. A notice was published in the Federal Register pursuant to
Section 6(b) of the Act on August 16, 2021 (86 FR 45750).
Suzanne Morris,
Chief, Premerger and Division Statistics, Antitrust Division.
[FR Doc. 2021-25689 Filed 11-23-21; 8:45 am]
BILLING CODE 4410-11-P
</pre></body>
</html>Indexed from Federal Register on November 24, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.